Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
3.100
+0.030 (0.98%)
At close: Aug 7, 2026, 4:00 PM EDT
3.060
-0.040 (-1.29%)
Pre-market: Aug 10, 2026, 7:42 AM EDT
Cronos Group Market Cap
Cronos Group has a market cap or net worth of $1.16 billion as of August 10, 2026. Its market cap has increased by 43.09% in one year.
Market Cap
1.16B
Enterprise Value
397.11M
1-Year Change
43.09%
Ranking
Category
Stock Price
$3.10
ChartMarket Cap Chart
Since February 27, 2018, Cronos Group's market cap has increased from $1.14B to $1.16B, an increase of 1.76%. That is a compound annual growth rate of 0.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 1.16B | 15.03% |
| Dec 31, 2025 | 1.01B | 30.41% |
| Dec 31, 2024 | 772.20M | -3.05% |
| Dec 29, 2023 | 796.50M | -17.14% |
| Dec 30, 2022 | 961.30M | -34.04% |
| Dec 31, 2021 | 1.46B | -41.04% |
| Dec 31, 2020 | 2.47B | -6.25% |
| Dec 31, 2019 | 2.64B | 42.01% |
| Dec 31, 2018 | 1.86B | 63.14% |
| Feb 27, 2018 | 1.14B | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Trulieve Cannabis | 1.68B |
| ANI Pharmaceuticals | 1.66B |
| Harrow | 1.51B |
| Xeris Biopharma Holdings | 1.45B |
| Phibro Animal Health | 1.39B |
| Alvotech | 1.36B |
| Eton Pharmaceuticals | 1.22B |
| Pacira BioSciences | 997.34M |